IV IRON TOOLKIT

Thank you for registering for the Beyond IDA: Identifying, Discussing, and Addressing Adverse Effects of IV Iron! You can watch the webinar here.

• Primers
  • Ferric Carboxymaltose (Injectafer®)
  • Ferric Derisomaltose (Monoferric®)
  • Ferric Gluconate (Ferrlecit®)
  • Ferumoxytol (Feraheme®)
  • Iron Dextran (Infed®)
  • Iron Sucrose (Venofer®)
• Product Comparison
• Safety Review of IV Iron Therapies: Blumenstein I, et al. Newer formulations of intravenous iron: a review of their chemistry and key safety aspects – hypersensitivity, hypophosphatemia, and cardiovascular safety. Expert Opin Drug Saf. 2021;20(7):757-769
• Hypophosphatemia Meta-Analysis: Schaefer B, et al. Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside—a systematic review and meta-analysis. British Journal of Clinical Pharmacology. 2021;87(5):2256-2273

If you want to learn more about other benign heme topics, click here to access our ITP toolkit!